HORGAN KEVIN 4
4 · Seres Therapeutics, Inc. · Filed Jan 29, 2019
Insider Transaction Report
Form 4
HORGAN KEVIN
Chief Medical Officer and EVP
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2019-01-25+30,000→ 30,000 totalExercise: $6.01Exp: 2029-01-24→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 25% of the shares on January 25, 2020. The remainder of the shares will vest in 12 equal quarterly installments thereafter.